Wolff-Parkinson-White syndrome drug prophylaxis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
{{Wolff-Parkinson-White syndrome}} | {{Wolff-Parkinson-White syndrome}} | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{ Sara.Zand}} {{CZ}} | ||
==Drug Prophylaxis In The Patient With Proven Tachyarrhythmias== | ==Drug Prophylaxis In The Patient With Proven Tachyarrhythmias== | ||
* Oral [[beta-blocker]], [[diltiazem]], and [[verapamil]] for prevention of [[AVRT]] in patients with out preexcitation in resting [[ECG]]. | * Oral [[beta-blocker]], [[diltiazem]], and [[verapamil]] for prevention of [[AVRT]] in patients with out preexcitation in resting [[ECG]]. |
Revision as of 12:38, 16 September 2020
Wolff-Parkinson-White syndrome Microchapters |
Differentiating Wolff-Parkinson-White syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Wolff-Parkinson-White syndrome drug prophylaxis On the Web |
Risk calculators and risk factors for Wolff-Parkinson-White syndrome drug prophylaxis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Sara Zand, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3]
Drug Prophylaxis In The Patient With Proven Tachyarrhythmias
- Oral beta-blocker, diltiazem, and verapamil for prevention of AVRT in patients with out preexcitation in resting ECG.
- Oral flecainide and propaphenone in patients with preexcitation in resting ECG that are not candidates for catheter ablation and do not have structural or ischemic heart disease.[1]
References
- ↑ Page, Richard L.; Joglar, José A.; Caldwell, Mary A.; Calkins, Hugh; Conti, Jamie B.; Deal, Barbara J.; Estes III, N.A. Mark; Field, Michael E.; Goldberger, Zachary D.; Hammill, Stephen C.; Indik, Julia H.; Lindsay, Bruce D.; Olshansky, Brian; Russo, Andrea M.; Shen, Win-Kuang; Tracy, Cynthia M.; Al-Khatib, Sana M. (2016). "2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia". Heart Rhythm. 13 (4): e136–e221. doi:10.1016/j.hrthm.2015.09.019. ISSN 1547-5271.